CD44 in rheumatoid arthritis
- PMID: 12723975
- PMCID: PMC165042
- DOI: 10.1186/ar746
CD44 in rheumatoid arthritis
Abstract
CD44 is a multistructural cell-surface glycoprotein that can theoretically generate close to 800 isoforms by differential alternative splicing. At present, several dozen isoforms are known. The polymorphic nature of CD44 might explain its multifunctionality and its ability to interact with many cell-surface and extracellular ligands, the principal one being hyaluronic acid (HA). Of the many CD44 functions, our review focuses on its involvement in cell-cell and cell-matrix interactions, as well as on its implication in the support of cell migration and the presentation of growth factors to their cognate receptors. Cells involved in pathological activities such as cancer cells and destructive inflammatory cells, and also normal cells engaged in physiological functions, use cell-surface CD44 for their localization and expansion at extravascular sites. This article reviews the evidence that the joint synovium of patients with rheumatoid arthritis (RA) contains considerable amounts of various CD44 isoforms as well as the HA ligand. The review also shows that anti-CD44 monoclonal antibody (mAb) directed against constant epitopes, shared by all CD44 isoforms, can markedly reduce the inflammatory activity of arthritis induced by collagen or proteoglycans in mice. Anti-CD44 mAb also interferes with the migration of RA synovial-like fibroblasts in vitro and is able to disturb the destructive interaction between RA synovial-like fibroblasts and the cartilaginous matrix. However, the transition from the experimental model to the patient's bedside is dependent on the ability to target the CD44 of cells engaged in RA pathology, while skipping the CD44 of normal cells.
Figures

Similar articles
-
CD44: structure, function, and association with the malignant process.Adv Cancer Res. 1997;71:241-319. doi: 10.1016/s0065-230x(08)60101-3. Adv Cancer Res. 1997. PMID: 9111868 Review.
-
Anti-CD44 treatment abrogates tissue oedema and leukocyte infiltration in murine arthritis.Nat Med. 1995 Jun;1(6):558-63. doi: 10.1038/nm0695-558. Nat Med. 1995. PMID: 7585123
-
CD44 involvement in experimental collagen-induced arthritis (CIA).J Autoimmun. 1999 Aug;13(1):39-47. doi: 10.1006/jaut.1999.0294. J Autoimmun. 1999. PMID: 10441166
-
CD44 is the physiological trigger of Fas up-regulation on rheumatoid synovial cells.J Immunol. 2001 Aug 1;167(3):1198-203. doi: 10.4049/jimmunol.167.3.1198. J Immunol. 2001. PMID: 11466334
-
CD44 cell adhesion molecules.Mol Pathol. 1999 Aug;52(4):189-96. doi: 10.1136/mp.52.4.189. Mol Pathol. 1999. PMID: 10694938 Free PMC article. Review.
Cited by
-
Get Spliced: Uniting Alternative Splicing and Arthritis.Int J Mol Sci. 2024 Jul 25;25(15):8123. doi: 10.3390/ijms25158123. Int J Mol Sci. 2024. PMID: 39125692 Free PMC article. Review.
-
Different expression of β subunits of the KCa1.1 channel by invasive and non-invasive human fibroblast-like synoviocytes.Arthritis Res Ther. 2016 May 10;18(1):103. doi: 10.1186/s13075-016-1003-4. Arthritis Res Ther. 2016. PMID: 27165430 Free PMC article.
-
Cells of the synovium in rheumatoid arthritis. Chondrocytes.Arthritis Res Ther. 2007;9(5):220. doi: 10.1186/ar2292. Arthritis Res Ther. 2007. PMID: 18001488 Free PMC article. Review.
-
Expression of Transcriptional Factors of T Helper Differentiation (T-bet, GATA-3, RORγt, and FOXP3), MIF Receptors (CD44, CD74, CXCR2, 4, 7), and Th1, Th2, and Th17 Cytokines in PBMC from Control Subjects and Rheumatoid Arthritis Patients.Curr Mol Med. 2024;24(9):1169-1182. doi: 10.2174/0115665240260976230925095330. Curr Mol Med. 2024. PMID: 37807647
-
Aspects of the biology of hyaluronan, a largely neglected but extremely versatile molecule.Wien Med Wochenschr. 2006 Nov;156(21-22):563-8. doi: 10.1007/s10354-006-0351-0. Wien Med Wochenschr. 2006. PMID: 17160372 Review.
References
-
- Lesley J, Hyman R, Kincade PW. CD44 and its interaction with extracellular matrix. Adv Immunol. 1993;54:271–335. - PubMed
-
- Naor D, Vogt Sionov R, Ish-Shalom D. CD44: structure, function and association with malignant process. Adv Cancer Res. 1997;71:241–319. - PubMed
-
- Lesley J, Hyman R. CD44 structure and function. Frontiers Biosci. 1998;3:d616–d630. - PubMed
-
- Naor D, Nedvetzki S, Golan I, Melnik L, Faitelson Y. CD44 in cancer. Crit Rev Clin Lab Sci. 2002;39:527–579. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous